Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × famitinib × Clear all

NCT06336954 2024-03-29

Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT02356991 2019-11-04

A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung